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Acetate-induced myocardial depression during hemodialysis
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Acetate-induced myocardial depression during hemodialysis for acute
renal failure. We studied the cardiovascular effects of hemodialysis in
five critically ill patients with ultrafiltration using, alternately, bicarbon-
ate and acetate in the dialysate. After 3 hr of dialysis with acetate,
significant decreases in both arterial pressure and stroke volume
resulted in lowered left ventricular stroke work (P < 0.025). This effect
persisted 30 mm after the end of the dialysis (P < 0.025). Differences in
the patients' cardiac preload were ruled out by similar pulmonary artery
balloon-occluded pressures during both types of dialysis. These obser-
vations suggest that dialysis with acetate can result in myocardial
depression. The use of bicarbonate dialysate is thus advisable for acute
hemodialysis in critically ill patients.
Depression myocardiaque induite par l'acetate au cours de l'hemodia-
lyse pour insuffisance renale aiguë. Chez cinq patients hospitalisés en
unite de soins intensifs, nous avons étudié.les effets cardiovasculaires
de l'hemodialyse avec ultrafiltration en utilisant successivement du
bicarbonate et de l'acétate dans le dialysat. Après 3 heures de dialyse a
l'acétate, une diminution importante de Ia pression artérielle et du vol-
ume ejectionnel ont conduit a un moindre travail ejectionnel du yen-
tricule gauche (P < 0,025). Cet effet a presisté 30 minutes après Ia fin
de Ia dialyse (P < 0,025). Une difference de precharge cardiaque chez
ces patients a été éliminée par Ia similarité des pressions occlusives de
l'artère pulmonaire dans les deux types de dialyse. Ces observations
suggérent que La presence d'acétate dans le dialysat peut entrainer une
depression myocardiaque. L'usage de dialysat au bicarbonate est donc
a conseiller pour l'hemodialyse aigue chez les patients en état critique.
Since the initial work by Mion et a! [ii, acetate has been
routinely used, as a technical convenience, for replacement of
bicarbonate in dialysis fluids. However, the use of acetate baths
for high-efficiency dialysis has been associated with a higher
incidence of arterial hypotension and symptoms such as nau-
sea, cramps, dizziness, and fatigue [2, 3]. This greater vascular
instability, which can even limit ultrafiltration [2], has been
related to the increased blood acetate concentration, rather
than to differences in acid-base status [3]. However, the under-
lying mechanism by which acetate induces arterial hypotension
is yet to be clarified. On the one hand, acetate has vasodilating
properties that could result in a decrease in vascular resistance
[4]. On the other hand, experimental studies suggest that
acetate infusion can result in a reduction in myocardial contrac-
tility [5, 6].
The influence of dialysate composition on patient tolerance to
dialysis may be too subtle to be appreciated easily in stable,
ambulatory chronic hemodialysis patients. Therefore, we corn-
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pared the hemodynamic effects of hemodialysis in five critically
ill patients by alternately using acetate and bicarbonate in the
dialysate. These patients were also selected because invasive
monitoring techniques had been instituted previously for opti-
mal management of cardiopulmonary problems.
Methods
The hemodynamic and metabolic courses of five critically ill
patients were studied during hemodialysis for acute renal
failure. The clinical data of the five patients are represented in
Table 1. Patient no. 1 had a history of high blood pressure and
moderate chronic renal failure and presented on admission with
a serum creatinine concentration of 1.9 mgldl. The other four
patients had no history of cardiovascular or renal disease.
In each patient, a pulmonary artery catheter (Swan Ganz
catheter 93A-l31-7F, Edwards Laboratories, Santa Ana, Cali-
fornia) had been inserted through an internal jugular vein and an
arterial catheter (Longdwell 16 gauge, Becton, Dickinson &
Co., Rutherford, New Jersey) had been introduced through the
femoral artery into the distal aorta prior to the study. No patient
was treated with inotropic or vasoactive drugs at the time of the
study. Four patients were treated with positive pressure venti-
lation (Servo 900B, Siemens-Elema, Solna, Sweden). A posi-
tive end-expiratory pressure of 5 cm H20 was used in two of
them (Table 1).
In each patient, one hemodialysis with acetate-containing
dialysate and one hemodialysis with bicarbonate-containing
dialysate were performed in a randomized order. The two
dialyses were performed at 24-hr intervals in four patients and
with a 6-day interval in patient no. 2 only. Between the two
dialyses, the fluid intake was determined such that the positive
fluid balance was equivalent to the fluid ultrafiltered during the
previous dialysis. The type of ventilation and the oxygen
administration were similar during the two dialyses included in
this study.
Dialysis was performed using a hollow fiber dialyzer with a
1.8-rn2 cellulosic membrane (Cordis-Dow Corporation, Miami,
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Table 1. Clinical data of the five patients°
Control End + 30 mn
+
Lodialvsist
Hemodialysis (5 patients),* P < 0.025
Fig. 1. Hemodynamic effects of dialysis with bicarbonate (circles) and
dialysis with acetate (squares) in the fivepatients. P < 0.025 between
dialysis with acetate and with bicarbonate. Abbreviations: AP, mea-
surements of mean arterial pressure; HR, heart rate; CO, cardiac
output; LVSW, left ventricular stroke work.
Florida). Dialysate flow was 500 mi/mm. A single catheter
(Desilet 1133.07, Vygon, Ecouen, France) was inserted percu-
taneously into a femoral vein and connected to a double pump
system (BL76OC, Beilco, Mirandola, Italy), which resulted in a
mean blood flow of 240 mllmin. Each dialysate contained: Na
140 mEq/liter, K 1.5 mEq/liter, Mg2 1 mEq/liter and Ca2
3.75 mEq/liter. Anion concentrations in bicarbonate-containing
dialysates were: C1 108.25 mEq/Iiter, HCO3 35 mEq/Iiter,
and CH3COO 3 mEq/liter; and in acetate-containing dialy-
sates: C1 109.25 mEq/liter and CH3COO 37 mEq/liter. Each
hemodialysis was conducted for 3 hr. Thirty minutes after the
onset of the dialysis without ultrafiltration, a transmembrane
pressure was set to achieve an ultrafiltration of 1750 ml during
the next 150 mm of dialysis. During the whole procedure, a
saline infusion was administered whenever necessary to main-
tain a mean arterial pressure above 70 mm Hg. The transmem-
brane pressure therefore was unchanged throughout hemodialy-
sis. We called negative fluid balance the difference between the
ultrafiltered volume and the amount of saline solution infused
during dialysis. Hemodynamic and laboratory data were ob-
tained before dialysis, immediately before the end of the
dialysis, and finally 30 mm after the end of the dialysis.
Hemodynamic data included measurements of mean arterial
pressure (AP), mean right atrial pressure (PRA), mean pulmo-
nary artery pressure (PPA), and mean pulmonary artery wedge
pressure (PAW), heart rate (HR), and cardiac output (CO). The
CO was measured by thermodilution technique utilizing a
computer (9520, Edwards Laboratories, Santa Ana, California).
At least three injections of cold (<3°C) lO-ml samples of
dextrose 5% in water were performed for each measurement.
Patient Sex
1 M
2 F
3 M
4 F
5 M
Age
52
Etiology of the
renal failure
Sequence of
hemodialysis
Type of
ventilation
IPPV
Fi02
0.40Septic shock Bic - Ac
39 Septic shock Bic - Ac CPPV 0.40
67 Aminoglycosides Bic - Ac Spontaneous 0.28
therapy
57 Crush syndrome Ac - Bic IPPV 0.40
55 Septic shock Ac - Bic CPPV 0.30
Abbreviations: IPPV, intermittent positive pressure ventilation; CPPV, continous positive pressure ventilation (with a positive end-expiratory
pressure of 5 cm H20); Bic, bicarbonate; Ac, acetate.
The type of ventilation and the inspired fraction in oxygen (Fi02) were similar for the two dialyses.
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Fig. 2. Left ventricular function curve [left ventricular stroke work
(LVSW) versus pulmonary artery balloon-occluded pressure (PAW)] of
the five patients during the two types qf hemodialysis (mean scsi).
Symbols: • bicarbonate; • acetate.
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The stroke volume (SV) was obtained by dividing CO by HR.
Left ventricular stroke work (LVSW) and systemic vascular
resistance (SVR) were calculated by the following formulas:
LVSW (g) = (AP — PAW) x SV x 0.0136
SVR (dynes sec cm5) = (AP — PRA) x 79.9/CO (2)
In four patients, plasma volumes were measured before each of
the two dialyses by isotopic dilution technique with radioiodin-
ated (I3J) human serum albumin [7].
Laboratory data included measurements of arterial blood
gases and concentrations of hemoglobin, electrolytes, and
lactate. Blood urea nitrogen and creatinine concentrations were
determined before and after dialysis. Arterial blood gases were
measured by an automated analyzer (ABL2, Radiometer, Co-
penhagen, Denmark) located in the intensive care unit.
Statistical data were analyzed by Student's t test for paired
and unpaired data. The results are expressed by the means
SEM. A P value less than 0.05 was considered significant.
Results
Hemodialysis using bicarbonate in the dialysate was well
tolerated in each of the five critically ill patients. During a
dialysis using acetate, patient no. 2 suddenly developed a rapid
atrial fibrillation associated with a severe arterial hypotension,
prompting us to stop the dialysis; another dialysis using acetate
was included in the study 6 days later.
Plasma volumes, measured in four of the five patients, were
similar before the dialysis with bicarbonate (56 6 mi/kg) and
before the dialysis with acetate (53 5 mi/kg). In both
conditions, the ultrafiltration rate was maintained constant at
11.7 mllmin. The decrease in arterial pressure was similar
during the two types of dialyses (Fig. 1), but the amount of fluid
infused to maintain adequate arterial pressure was larger during
acetate dialysis than during bicarbonate dialysis. The negative
fluid balance averaged 1710 40 ml during the dialysis using
bicarbonate but only 1280 210 ml during the dialysis using
acetate.
The evolution of the cardiac output was comparable during
the two types of dialyses. However, we observed a significant
increase in heart rate from 101 8 to 116 11 beats/mm (P <
0.05) during dialysis using acetate, whereas no such increase
was observed during dialysis with bicarbonate. These differ-
ences in stroke volume and in arterial pressure between the two
types of dialyses resulted in a significantly lower left ventricular
stroke work at the end of the dialysis using acetate (P < 0.025).
These differences were still significant 30 mm after the end of
the dialysis (P < 0.025).
The relationship between the pulmonary artery wedge pres-
sure, used as a reflect of the left ventricular filling pressure and
the left ventricular stroke work, is represented in Figure 2. For
the five patients, the PAW was 16.4 1.9 mm Hg before
dialysis using bicarbonate and 14.6 2.6 mm Hg before the
dialysis using acetate. These pressures were also very similar
before the end of the two dialyses as well as 30 mm after the
discontinuation of the procedure. Therefore, the differences in
left ventricular stroke work were observed in the presence of
comparable PAW.
Systemic vascular resistances increased from 1200 310 to
1360 310 dynes sec cm5 (P < 0.01) during bicarbonate
dialysis and decreased from 1330 270 to 1280 220 dynes sec
cm5 (NS) during acetate dialysis. The differences in SVR
between the two types of dialyses were not statistically signifi-
cant at any time.
Metabolic acidosis was corrected at the end of the dialysis
using bicarbonate (Table 2). There was a moderate decrease in
pH and serum bicarbonate concentration at the end of the
dialysis using acetate. None of the patients developed increased
lactacidemia.
Discussion
A higher incidence of arterial hypotension during high-effi-
ciency dialysis with acetate-containing dialysate has been docu-
mented by Graefe et al [2] and confirmed in other studies [3, 8,
9]. These observations were challenged recently by Borges et al
[103 who reported a similar incidence in hypotensive episodes
and a comparable ultrafiltration in 30 acute renal failure patients
dialyzed alternately with acetate and bicarbonate in the dialy-
sate. It is very likely that differences in the clinical status of the
patients studied and in the efficiency of the dialysis can account
largely for these discrepancies [11].
The precise nature of the greater cardiovascular instability
during acetate dialysis is still a matter of debate [11]. In a study
of the effects of acetate and pyruvate on circulation in dogs,
Liang and Lowenstein [12] observed an increase in cardiac
output, in peak rate of increase of left ventricular pressure (dP/
dt), and in coronary blood flow during acetate infusion. These
Table 2. Laboratory values of the five patients before and at the end of the two dialyses (means SEM)
Bicarbonate (N 5) Acetate (N = 5)
Before dialysis End of dialysis Before dialysis
Pa02, mm Hg 87 9 86 12 85 5
pH 7.37 0.03 7.42 0.02 7.38 0.04
PaCO2, mm Hg 34.4 2.5 36.2 2.5 35.0 1.4
Bicarbonate, mEq/liter 19.7 2.1 23.0 0.9 20.8 2.4
Lactate, mEqiliter 1.0
Potassium, mEq/liter 4.5
Calcium, mg/liter 85
Phosphate, mg/liter 50
Hemoglobin, glliter 99
BUN, mg/liter 1060
Creatinine, mg/liter 60
0.3
0.5
5
6
4
130
11
1.2
3.3
95
31
104
560
38
0.3
0.3
8
6
8
100
+ 7
End of dialysis
86 8
7.34 0.05
33.6 4.3
17.9 2.6
1.4 2.6
3.2 0.4
107 2
37 8
99 10
540 140
37 11
1.1
4.2
96
43
97
1010
57
0.3
0.4
+ 5
8
7
+ 180
17
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authors suggested that these effects were due to acetate-
induced vasodilation and that they were related to the increased
release of adenosine monophosphate secondary to acetate
metabolism. On the other hand, Kirkendol et al [5, 61 reported
that acetate bolus in dogs resulted in a dose-dependent reduc-
tion in myocardial contractile force measured by a strain gauge
arch on the myocardium. A similar reduction in myocardial
contractility was observed in isolated rabbit papillary muscle
[6]. Aizawa et al [8] observed, during patient hemodialysis with
acetate dialysate, a decrease in peripheral vascular resistance
associated with an increase in limb flow measured by venous
occlusion plethysmography. They also observed a more severe
reduction in myocardial contractility with acetate than with
bicarbonate when they measured the ratio of the pre-ejection
period to the left ventricular ejection time (PEP/ET).
In this study, in which the ultrafiltration rate was kept
constant, the amount of intravenous fluid required to maintain
adequate arterial pressure was larger during dialysis using
acetate than during dialysis using bicarbonate. A key finding
was the significantly lower left ventricular stroke work during
acetate dialysis when compared to bicarbonate dialysis. Reduc-
tion in stroke work could result from changes in afterload,
preload, and/or stroke volume.
A greater left ventricular afterload during acetate dialysis was
excluded by the measurement of the systemic vascular resist-
ance. To the contrary, there was a tendency for the systemic
vascular resistance to remain lower during acetate dialysis. This
was expected in view of the vasodilating effects of the acetate
ion [4, 12].
Differences in the initial fluid status of these patients were
avoided carefully. Yet, undetected differences could have re-
sulted in changes in left ventricular preload between the two
dialyses. We used the PAW as a reflect of the left ventricular
end diastolic pressure (LVEDP). We ackowledge there could be
some discrepancy between PAW and LVEDP, especially in
critically ill patients treated for four of them by positive
pressure ventilation. However, each patient was his own con-
trol and the ventilatory conditions were unchanged during the
entire study. Therefore, we considered that the relationship
between PAW and LVEDP was unaffected during the period of
observation. Hence, the left ventricular filling pressures were
similar during the two types of dialysis.
Acute changes in left ventricular compliance could have
occurred during hemodialysis with acetate. More specifically,
the significant increase in heart rate during acetate dialysis
could affect the pressure-volume relationship of the left ventri-
cle by changes in myocardial viscosity Fl51. These differences
could mask a reduced preload due to a decrease in venous
return to the left heart. However, the small difference in the
systemic vascular resistance between the two types of dialysis
renders this consideration unlikely. Therefore, we can reason-
ably consider that the difference in left ventricular stroke work
were observed in the absence of significant changes in cardiac
preload between the two types of dialysis.
The significantly lower left ventricular stroke work during
dialysis with acetate was due essentially to changes in stroke
volume. The observation of a lower stroke volume and a higher
heart rate when the dialysate contains acetate is consistent with
the recent observations of Hampl et al during conventional
dialysis using acetate [13]. The significant increase in heart rate
during acetate dialysis with acetate is hardly explained by a
direct effect of acetate upon the sinus node, since a decrease in
heart rate generally follows acetate administration in animals [5,
6]. The increase in heart rate rather resulted from the decrease
in stroke volume. In the absence of changes in preload or
afterload, myocardial depression is the most likely explanation
for the lower stroke volume observed during acetate dialysis.
Since there was no significant arterial vasoconstriction, the
increase in heart rate represented the only compensatory mech-
anism to maintain arterial pressure in the presence of a negative
inotropic effect of acetate.
Differences in acid-base status were too small to account for
the observed differences in myocardial performance between
the two types of dialysis [16]. The use of a large surface type of
dialyzer can result in a rapid transfer of acetate, which can
exceed the metabolism of the patient [17]. Novello, Kelsch, and
Easterling [9] have described a selected group of "acetate
intolerant" patients, who developed high plasma acetate con-
centrations in excess of 15 mmoles/liter during dialysis. Impair-
ment of the acetate metabolism in these critically ill patients is
likely, although an increased sensitivity of these patients'
myocardium to acetate cannot be excluded,
In conclusion, the alternative use of bicarbonate and acetate
in the dialysate strongly suggested in five acutely ill patients an
impairment of the myocardial performance during dialysis using
acetate. This observation does not imply that the use of acetate
dialysates should be abandoned definitely for routine hemodial-
ysis. However, bicarbonate-containing dialysates should be
recommended strongly for dialysis in critically ill patients.
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